S029 Treating Severe Skin Diseases in Children
DESCRIPTION
During this session, attendees will review challenging topics faced in the pediatric population. Speakers will provide updates in the diagnosis and management of several inflammatory and autoimmune conditions in children. Learners will review an approach to challenging pediatric pigmented lesions. Speakers will answer audience questions during hourly Q&As.
LEARNING OBJECTIVES
Diagnose inherited, inflammatory, infectious and autoimmune dermatologic diseases in children.
Select systemic, topical and other therapies for severe skin disease in children.
Develop an approach to managing children with severe skin disease.
SCHEDULE
9:00 AM
Management of Melanoma and Spitzoid Melanocytomas in Children
Elena B. Hawryluk, MD, PhD, FAAD
9:25 AM
Update on Management of Pediatric Hidradenitis Suppurativa
Cathryn Joy Sibbald, MD, FAAD
9:50 AM
Q&A Drs. Hawryluk and Sibbald
Elena B. Hawryluk, MD, PhD, FAAD, Cathryn Joy Sibbald, MD, FAAD
10:00 AM
Updates on Management of Immunobullous Diseases in Children
Raegan D. Hunt, MD, PhD, FAAD
10:25 AM
Updates on Management of Juvenile Dermatomyositis
Leslie Castelo-Soccio, MD, PhD, FAAD
10:50 AM
Q&A Drs. Castelo-Soccio and Hunt
Leslie Castelo-Soccio, MD, PhD, FAAD, Raegan D. Hunt, MD, PhD, FAAD
11:00 AM
Update on Management of Alopecia Areata
Cathryn Joy Sibbald, MD, FAAD
11:25 AM
Q&A Dr. Sibbald
Cathryn Joy Sibbald, MD, FAAD
DIRECTOR
Christine T. Lauren, MD, FAAD
SPEAKERS
Leslie Castelo-Soccio, MD, PhD, FAAD
Elena B. Hawryluk, MD, PhD, FAAD
Raegan D. Hunt, MD, PhD, FAAD
Cathryn Joy Sibbald, MD, FAAD
HANDOUTS
DISCLOSURES
Leslie Castelo-Soccio, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Elena B. Hawryluk, MD, PhD, FAAD
Apogee Therapeutics – Advisory Board(Honoraria); UpToDate, Inc – Other(Other Financial Benefit);
Raegan D. Hunt, MD, PhD, FAAD
Chiesi Farmaceutici – Advisory Board(Fees); Disc Medicine – Advisory Board(Fees); GlycosBio, Inc – Advisory Board(Stock Options), Stockholder Private Company(Stock); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Fees); Palvella Therapeutics – Investigator(Fees); Pfizer Inc. – Advisory Board(Fees); Rhythm Pharmaceuticals, Inc. – Investigator(Fees); Timber Pharmaceuticals – Data Safety Monitoring Board(Fees); UpToDate, Inc – Other(Honoraria);
Christine T. Lauren, MD, FAAD
No financial relationships exist with ineligible companies.
Cathryn Joy Sibbald, MD, FAAD
AbbVie – Speaker(Honoraria); Incyte – Advisory Board(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Honoraria); Miravo – Advisory Board(Honoraria); Novartis – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria), Speaker(Honoraria); UCB – Speaker(Honoraria);